US Edition
Common diabetes drug associated with “exceptional longevity”
Summary by New Atlas
1 Articles
1 Articles
All
Left
Center
Right
Common diabetes drug associated with “exceptional longevity”
A recent study led by UC San Diego reveals that metformin, a first-line treatment for type 2 diabetes, may help women with diabetes live longer, reducing the risk of death by 30%. The research, using a target trial emulation framework, suggests that metformin could contribute to exceptional longevity by activating longevity-related genes like FOXO3. Learn more about how metformin may extend lifespan and its role in aging and disease prevention.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
